A man showing early signs of a heart attack — detected by a bot tracking his heart activity from a sensor on his wrist — is picked up by a self-driving car that checks his vital signs on the way to the hospital. There, his doctors video-conference with a specialist, who assesses his symptoms through a Skype-like screen and recommends a treatment plan.

A unanimous Supreme Court is speeding up the time for generic biotech drugs to become available to the public in a ruling that means a loss of billions in sales to the makers of original versions.

Moderate Republican senators from Medicaid expansion states are dropping their opposition to ending the Affordable Care Act's enhanced federal funding for expansion as they embrace the idea of winding down that funding over several years.

Medi-Cal patients are swamping California emergency rooms in greater numbers than they did before the Affordable Care Act took effect, despite predictions that the health law would ease the burden on ERs.

A Nevada drug-pricing bill that targeted diabetes drugmakers didn’t make it past the governor’s veto pen, but state lawmakers renewed their efforts with a new bill that not only zeroes in on pharma, but pharmacy benefit managers, too. And this time, the governor is more supportive, according to one report.

Gov. Brian Sandoval on Friday vetoed a bill that would have required drug manufacturers to notify the state in advance of planned price increases for diabetes-related drugs, among other provisions.